{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:10:02Z","timestamp":1789193402924,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001515","name":"Cure Kids","doi-asserted-by":"publisher","award":["7012"],"award-info":[{"award-number":["7012"]}],"id":[{"id":"10.13039\/501100001515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jinf.2025.106506","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T18:34:21Z","timestamp":1747247661000},"page":"106506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["High dose, subcutaneous injections of benzathine penicillin G (SCIP) to prevent rheumatic fever: A single arm, phase IIa trial of safety and pharmacokinetics"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3461-7223","authenticated-orcid":false,"given":"Julie","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8276-6784","authenticated-orcid":false,"given":"Sam","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhevindri","family":"Moodley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1092-5715","authenticated-orcid":false,"given":"Hazel","family":"Dobinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneka","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9792-7838","authenticated-orcid":false,"given":"Brioni","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Page-Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Batty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1182-9792","authenticated-orcid":false,"given":"Jonathan","family":"Carapetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4334-5351","authenticated-orcid":false,"given":"Laurens","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jinf.2025.106506_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/QCO.0b013e3283511d27","article-title":"Streptococcal skin infection and rheumatic heart disease","volume":"25","author":"Parks","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jinf.2025.106506_bib2","article-title":"Acute rheumatic fever and rheumatic heart disease","volume":"2","author":"Carapetis","year":"2016","journal-title":"Nat Rev Dis Prim"},{"issue":"5","key":"10.1016\/j.jinf.2025.106506_bib3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMp078039","article-title":"Rheumatic heart disease in developing countries","volume":"357","author":"Carapetis","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jinf.2025.106506_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/jpc.12808","article-title":"Historical aspects of rheumatic fever","volume":"51","author":"Steer","year":"2015","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"10.1016\/j.jinf.2025.106506_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3201\/eid2701.191791","article-title":"Rising ethnic inequalities in acute rheumatic fever and rheumatic heart disease, New Zealand, 2000-2018","volume":"27","author":"Bennett","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"19","key":"10.1016\/j.jinf.2025.106506_bib6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM195505122521901","article-title":"Prophylaxis against group A streptococci in rheumatic fever; the use of single monthly injections of benzathine penicillin G","volume":"252","author":"Stollerman","year":"1955","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jinf.2025.106506_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025308","article-title":"Serum penicillin G levels are lower than expected in adults within two weeks of administration of 1.2 million units","volume":"6","author":"Broderick","year":"2011","journal-title":"PloS One"},{"issue":"A","key":"10.1016\/j.jinf.2025.106506_bib8","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0954-6111(01)90023-X","article-title":"The hidden impact of antibacterial resistance in respiratory tract infection. Re-evaluating current antibiotic therapy","volume":"95","author":"Craig","year":"2001","journal-title":"Respir Med"},{"key":"10.1016\/j.jinf.2025.106506_bib9","unstructured":"Anderson, A., Mills, C., Rentta, N., Devlin, G., Farrant, B., Kando, I, et al., (2025). Aotearoa New Zealand Guidelines for the Prevention, Diagnosis, and Management of Acute Rheumatic Fever and Rheumatic Heart Disease: 2024 Update. Wellington: Health New Zealand | Te Whatu Ora."},{"issue":"24","key":"10.1016\/j.jinf.2025.106506_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010223","article-title":"How many doses make a difference? An analysis of secondary prevention of rheumatic fever and rheumatic heart disease","volume":"7","author":"de Dassel","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"16","key":"10.1016\/j.jinf.2025.106506_bib11","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.1952.03680160021005","article-title":"Prophylaxis against group A streptococcal infections in rheumatic fever patients; use of new repository penicillin preparation","volume":"150","author":"Stollerman","year":"1952","journal-title":"J Am Med Assoc"},{"issue":"8","key":"10.1016\/j.jinf.2025.106506_bib12","first-page":"499","article-title":"N,N'-dibenzylethylenediamine penicillin: preparation and properties","volume":"1","author":"Szabo","year":"1951","journal-title":"Antibiot Chemother (Northfield)"},{"issue":"7","key":"10.1016\/j.jinf.2025.106506_bib13","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/jac\/dkz076","article-title":"A population pharmacokinetic study of benzathine benzylpenicillin G administration in children and adolescents with rheumatic heart disease: new insights for improved secondary prophylaxis strategies","volume":"74","author":"Hand","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.jinf.2025.106506_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009399","article-title":"High risk of early sub-therapeutic penicillin concentrations after intramuscular benzathine penicillin G injections in Ethiopian children and adults with rheumatic heart disease","volume":"15","author":"Ketema","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"10.1016\/j.jinf.2025.106506_bib15","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/INF.0b013e31825051d4","article-title":"Factors associated with loss of penicillin G concentrations in serum after intramuscular benzathine penicillin G injection: a meta-analysis","volume":"31","author":"Broderick","year":"2012","journal-title":"Pedia Infect Dis J"},{"issue":"11","key":"10.1016\/j.jinf.2025.106506_bib16","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1128\/AAC.02744-14","article-title":"A population pharmacokinetic modeling approach shows that serum penicillin G concentrations are below inhibitory concentrations by two weeks after benzathine penicillin G injection in the majority of young adults","volume":"58","author":"Neely","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"24","key":"10.1016\/j.jinf.2025.106506_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010223","article-title":"How many doses make a difference? An analysis of secondary prevention of rheumatic fever and rheumatic heart disease","volume":"7","author":"de Dassel","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.jinf.2025.106506_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0022-3476(86)81009-5","article-title":"Rheumatic fever recurrences: controlled study of 3-week versus 4-week benzathine penicillin prevention programs","volume":"108","author":"Lue","year":"1986","journal-title":"J Pedia"},{"issue":"12","key":"10.1016\/j.jinf.2025.106506_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-064022","article-title":"Study protocol for controlled human infection for penicillin G against Streptococcus pyogenes: a double-blinded, placebo-controlled, randomised trial to determine the minimum concentration required to prevent experimental pharyngitis (the CHIPS trial)","volume":"12","author":"Hla","year":"2022","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.jinf.2025.106506_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.101038","article-title":"Establishing the lowest penicillin concentration to prevent pharyngitis due to Streptococcus pyogenes using a human challenge model (CHIPS): a randomised, double-blinded, placebo-controlled trial","volume":"6","author":"Hla","year":"2025","journal-title":"Lancet Microbe"},{"issue":"10","key":"10.1016\/j.jinf.2025.106506_bib21","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1093\/jac\/dkaa282","volume":"75","author":"Kado","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2025.106506_bib22","first-page":"S301","article-title":"Subcutaneous infusions of high-dose benzathine penicillin G (SCIP) is safe, tolerable and potentially suitable for less frequent dosing for rheumatic heart disease secondary prophylaxis","volume":"31","author":"Kado","year":"2022","journal-title":"Heart\u00a0Lung Circ"},{"issue":"5","key":"10.1016\/j.jinf.2025.106506_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302493","article-title":"\u201cHurts less, lasts longer\u201d; a qualitative study of experiences of young people receiving high-dose subcutaneous injections of benzathine penicllin G to prevent rheumatic heart disease in New Zealand","volume":"19","author":"Cooper","year":"2024","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.jinf.2025.106506_bib24","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/jac\/dkz076","article-title":"A population pharmacokinetic study of benzathine benzylpenicillin G administration in children and adolescents with rheumatic heart disease: new insights for improved secondary prophylaxis strategies","volume":"74","author":"Hand","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2025.106506_bib25","series-title":"New Zealand data sheet - BICILLIN L-A\u00ae","author":"Medsafe","year":"2022"},{"issue":"8","key":"10.1016\/j.jinf.2025.106506_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00252-17","article-title":"Penicillin dried blood spot assay for use in patients receiving intramuscular benzathine penicillin G and other penicillin preparations to prevent rheumatic fever","volume":"61","author":"Page-Sharp","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jinf.2025.106506_bib27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1197\/aemj.10.4.390","article-title":"Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department","volume":"10","author":"Bijur","year":"2003","journal-title":"Acad Emerg Med"},{"issue":"1-2","key":"10.1016\/j.jinf.2025.106506_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3959(03)00176-3","article-title":"What decline in pain intensity is meaningful to patients with acute pain?","volume":"105","author":"Cepeda","year":"2003","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.jinf.2025.106506_bib29","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/jac\/dkac231","article-title":"Population pharmacokinetic study of benzathine penicillin G administration in Indigenous children and young adults with rheumatic heart disease in the Northern Territory, Australia","volume":"77","author":"Kado","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"22","key":"10.1016\/j.jinf.2025.106506_bib30","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.3390\/ijerph16224515","article-title":"Risk factors for acute rheumatic fever: Literature review and protocol for a case-control study in New Zealand","volume":"16","author":"Baker","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jinf.2025.106506_bib31","article-title":"Risk factors for acute rheumatic fever: a case-control study","volume":"26","author":"Baker","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.jinf.2025.106506_bib32","series-title":"Group A Streptococcal sore throat management guideline. 2019 Update","author":"Heart Foundation of New Zealand","year":"2019"},{"issue":"26","key":"10.1016\/j.jinf.2025.106506_bib33","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/j.vaccine.2019.03.059","article-title":"Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): Establishing a group A Streptococcus pharyngitis human infection study","volume":"37","author":"Osowicki","year":"2019","journal-title":"Vaccine"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325001008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325001008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:08:19Z","timestamp":1785330499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445325001008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0163445325001008"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106506","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High dose, subcutaneous injections of benzathine penicillin G (SCIP) to prevent rheumatic fever: A single arm, phase IIa trial of safety and pharmacokinetics","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106506","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106506"}}